The Centers for Medicare & Medicaid Services appears to be quietly considering Palantir to support its yearslong efforts to ...
The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
Update, December 12: As a technical matter, commenter Laurie Fenton Ambrose is correct that CMS did not officially propose coverage with evidence development (CED), and this post has been edited to ...
CMS’ Innovation Center is offering the third and final session of its ACO Accelerated Development Learning Sessions. ACO Accelerated Development Learning Sessions are designed to provide executive ...
The CMS' long-standing hospital readmissions penalty program has taken quite a beating recently from members of the research community over problems with its underlying measures. But while criticism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback